Health & Wellbeing

A man who had to "beg" to get an MRI scan because of the Covid-19 crisis has died of cancer, his family have said. Sherwin Hall, 27, from Leeds, first went to hospital on 23 March suffering leg pain but was misdiagnosed and sent away with a course of antibiotics.

After 13 visits in four weeks a scan on 26 May revealed a tumour in his pelvis and 30 small tumours on his lungs. Leeds Teaching Hospitals NHS Trust said it had maintained scanning for all "urgent interventions".

Mr Hall's wife LaTroya said had his cancer been found sooner "it is likely he would still be here today". Before his death, Mr Hall said he "kept begging" for a scan but was told services had been "slowed down because of the coronavirus".

In July, he featured in a special BBC programme Britain's Cancer Crisis. Mrs Hall, who is being supported by the Catch Up With Cancer Campaign, said she was "devastated" and had "lost the love of my life".

The campaign was launched by the parents of Macclesfield beautician Kelly Smith who died after her treatment for bowel cancer was stopped as a result of the pandemic. Mrs Hall said:

"It worries me that the government and NHS leaders continue to say cancer services are back to normal; our family's experience has been that, even now, this is simply not the case.

"Even if services were back at pre-pandemic levels, that is not enough. The cancer backlog also needs to be cleared." Cancer charity MacMillan said the backlog of cancer patients from the first lockdown was 50,000 while there might be twice that number as a result of the second lockdown.

A spokeswoman for Leeds Teaching Hospitals NHS Trust said: "We would like to offer our heartfelt condolences to Mr Hall's family at this very difficult time." She said the trust had maintained scanning for all "urgent interventions" throughout the pandemic and had operated in accordance with Nice guidelines.

A Department of Health and Social Care spokeswoman said cancer diagnosis and treatment had "remained a priority" during the pandemic and said the government had given £3bn to tackle the impact of Covid.

People with a history of significant allergic reactions should not have the Pfizer/BioNTech Covid jab, regulators say. It came after two NHS workers had allergic reactions had their jabs.

The advice applies to those who have had reactions to medicines, food or vaccines, the Medicines and Healthcare products Regulatory Agency said. The two people had a reaction shortly after having the new jab, had treatment and are both fine now.

They are understood to have had an anaphylactoid reaction, which tends to involve a skin rash, breathlessness and sometimes a drop in blood pressure. This is not the same as anaphylaxis which can be fatal.

Both NHS workers have a history of serious allergies and carry adrenaline pens around with them.

Professor Stephen Powis, medical director for the NHS in England, said both individuals were recovering well. He said this was "common with new vaccines", describing it as a precautionary measure.

Dr June Raine, head of the MHRA, said it was only right to take this step now that "we've had this experience". Reactions like this are uncommon, but do happen with other vaccines, including the annual flu jab.

Several thousand people were vaccinated on Tuesday in hospital clinics on the first day of the UK rollout of the new Covid jab.

Prof Peter Openshaw, an expert in immunology at Imperial College London, said: "The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that this monitoring system is working well."

NHS England and NHS Improvement have confirmed that Birmingham and Solihull Sustainability and Transformation Partnership’s (STPs) application to become an Integrated Care System (ICS) has been approved. The ICS will now move forward at pace, to enable it to deliver its full ambition by April 2022.

In an integrated care system, NHS organisations, in partnership with local councils and other partners, take collective responsibility for managing resources, delivering NHS care, and improving the health of the population they serve.

This is a crucial step for the Birmingham and Solihull system, recognising significant partnership working and collaboration over recent years across the NHS and local government. Whilst there is more work to do to create the ICS, it will bring about more improvements in health outcomes for local people, reducing health inequalities, promoting continuity of care, and making practical improvements to people’s lives, as well as creating more support, time and space for staff to collaborate and deliver their role more effectively, in a safe and compassionate way. The ICS will be able to do this by looking at the wider determinants of health and wellbeing, in a much more joined-up and unified way.

Paul Jennings, Birmingham and Solihull ICS Lead, said: “This is fantastic news; we are passionate about the difference that we can make by working together, to tackle the unacceptable health inequalities we have across the area. People living in Birmingham and Solihull don’t understand the boundaries or differences of our organisations, as they already expect us to be working together, and too often experience issues where we aren’t fully ‘joined up’. By working together, we can take big decisions around how and where care is delivered, to ensure we are making the most impact. By integrating how we make decisions together, holding  ourselves to account about how we offer and deliver care, we believe we are more likely to close the health and wellbeing, care, quality and financial gaps across our area. Ultimately, we want Birmingham and Solihull to be the best place to live and work.”

Dame Yve Buckland, who has recently been appointed as Chair of the ICS, said: “It’s a privilege to take on the role of Chair for the Birmingham and Solihull ICS. As ICS partners, we serve a large, diverse and vibrant region with incredible examples of innovative health and social care and many world-class services. However, there remain deep pockets of inequality and variation. As we emerge from the pandemic, focussing on integration has never been more important. We have an opportunity to close the gaps and create effective, holistic, person-centred pathways which support the citizens of Birmingham and Solihull to live healthier and happier lives.”

Rebecca Farmer, Director of Strategic Transformation (Birmingham and Solihull), NHS England and NHS Improvement added: “It is positive news that Birmingham and Solihull STP has been designated as an Integrated Care System. This will bring further health and care benefits to its population through joined-up working across the NHS, local authorities and other care giving organisations. The pandemic has accelerated this work and further integration will be critical to enable the system to address the underlying health inequalities and social and economic consequences of COVID for patients and the wider community across Birmingham and Solihull.”

The armed forces could help transport further stocks of the Pfizer/BioNTech vaccine from Belgium to the UK, with vaccinations due to begin today.

Asked if a no-deal Brexit could delay supplies, James Cleverly said it was a "top priority" and the government would look to ensure supplies were available "in whatever circumstance".

Military personnel are already helping to construct vaccination centres. Health Secretary Matt Hancock tweeted all parts of the UK had vaccine doses.

Front-line health staff, those over 80, and care home workers will be first in line for the vaccine.

In England, 50 hospitals have been initially chosen to serve as hubs for administering it.

Scotland, Wales, and Northern Ireland will also begin their vaccination programmes from hospitals today. The government announced a further 14,718 people had tested positive for the virus while a further 189 people had died within 28 days of a positive test - taking the total by that measure to 61,434.

The Ministry of Defence said 60 military planners are working with the government's vaccine task force, with a further 56 personnel helping to construct vaccination centres. Armed Forces minister James Heappey said around 13,500 military personnel were on "high readiness" - with more than 2,000 deployed so far to help with testing and the government's Covid response.

Refrigerated containers holding the vaccine doses, which need to be kept at -70C, have been arriving in the UK from Belgium, where it is made, and are being prepared to be moved from secure locations to the hospitals. Asked whether the armed forces would be used to help transport the vaccine to the UK, Mr Cleverly said: "Potentially - we are looking at non-commercial flight options."

In response to concerns a no-deal Brexit could cause delays in getting the vaccine into the UK, he said: "This is such an important product, it's probably perhaps the most important product, so we will look to ensure that those supplies are available in the UK in whatever circumstance."

Asked to confirm if this meant the armed forces would be used if needed, he said: "If we need to." It comes as talks between the UK and the EU continue in a bid to reach a post-Brexit trade deal.

Downing Street did not deny that RAF flights could be used to bring supplies of the vaccine over from other European countries if there were problems at ports caused by a no-deal Brexit. The prime minister's official spokesman would not comment on specific plans for "security reasons". But he said "the military will have a role to play in what's been an enormous logistical challenge and I'm sure they will continue to do so as we move forward".

About 800,000 doses of the vaccine are expected to be available in the United Kingdom from next week.mSo far the government has ordered a total of 40 million doses - enough to vaccinate 20 million people, with two shots each, 21 days apart.

With limited quantities initially available, elderly people who are already attending hospital as an outpatient, as well as those who are being discharged after a hospital stay, will be among the first to receive the jab. Others over the age of 80 will be invited to attend the hospital to receive a jab, and care home providers will be able to book their staff into vaccination clinics.

Any appointments not used for these groups will be used for healthcare workers who are at highest risk of serious illness from the virus.

Chris Hopson, chief executive of NHS Providers - which represents hospitals and other NHS trusts in England - said people over 80 should not be concerned if they did not receive a letter calling them to be vaccinated this month, as the "vast majority" of people would have to wait until next year.

Asked whether the Queen, who is 94, would receive the vaccination this week, the prime minister's official spokesman said it was a matter for Buckingham Palace. However, he added: "It is obviously a statement of fact that the Queen and Prince Philip are over 80 and are in a priority group."

Although care home residents and staff were placed at the top of the priority list agreed by the Joint Committee on Vaccination and Immunisation (JCVI), they are not getting the very first vaccinations. The government has explained this is because the chosen hospital hubs already have the facilities to store the vaccine at the required temperature of -70C. But Health Secretary Matt Hancock said the government was doing everything it could to overcome "significant challenges" to ensure care home residents were vaccinated as soon as possible.

British technology company VST Enterprises has today confirmed it has developed the world’s first secure 5 In 1 digital health passport and wallet. V-Health Passport is a crucial ‘safe technology enabler’ in reviving global economies, home lives and helping Governments, business and industry to start returning to work and normality.

The cross border, cross corporation V-Health Passport can be used by international Governments, consumers and companies to authenticate a person’s true identity, their Covid test results and vaccinations. This ‘enabler’ allows them to prove their test and/or vaccination status. Uniquely the V-Health Passport has its own contact tracing capability using anonymised data, whilst also protecting citizen’s data and privacy with a concept in the vein of ‘self-sovereign identity’.

Manchester headquartered VSTE have innovated the V-Health Passport to be the most secure digital health passport and wallet in the world, but at the same time multi-functional and future proof to deal with all future pandemics ;

The V-Health Passport has 5 key ‘enabling’ features to its technology:

• Powered by the world’s most secure cyber security coding technology VCode® it is the world’s most secure ‘next generation’ code scanning technology using a closed loop system with end to end encryption and 2.2 Quintillion collision free codes (A VCode® can only exist once due to being encoded from a centralised system).

• V-Health Passport is a test agnostic system so it can record results from all global Covid testing manufacturers and protocols from PCR to rapid antigen and antibody testing. 

• V-Health Passport also has its own unique contact tracing capability ‘True Contact™’ built within the technology designed for travel, sports stadiums, venues, factories, offices and construction sites. 

• The ultra-secure platform can now also hold vaccination records of all the major vaccination manufacturers which will be crucial in a person validating they have been vaccinated, the vaccine type, batch, dosage and date.

• Uniquely V-Health Passport is the only health wallet and cross border platform in the world that is multi-functional and GDPR compliant. It allows acts like ‘self sovereign identity’, meaning a citizen’s personal data is protected and they choose what they want to share and with whom they want to interact or authorise.

But at the same time tech boss Louis-James Davis - CEO of VST Enterprises  warned of the potential dangers and reliance on using QR code scanning technology within any form of health passport for airline travel or entry into a venue or workplace which could lead to potential security breaches of personal data and information.

It follows the hack and breach earlier this year of the former Australian Prime Minister Tony Abbot whose Quantas airline boarding card was hacked and details revealed including his passport number, mobile phone number and Qantas airline messages referring to the former PM.

Louis-James Davis went on to state that both bar codes and QR codes - which represent first and second generation technology - are unsecure and vulnerable to hacking. 

“QR codes were originally developed as a scanning technology for close proximity car parts tracking, a world away from Identity and banking use cases and now digital health passports. It was then used to skip the input of websites in marketing and promotional purposes. They were simply never designed with security or privacy in mind… they are simply not fit for purpose and should not be used at all in any form for delivery of sensitive information, travel or event tickets or health passport. QR codes can be subject to a process called ‘Attagging or ‘cloning.’  Louis-James Davis said.

Davis also warned that the public will not tolerate breaches of their personal data and information along with their already existing and heightened concerns over privacy during the pandemic.  He continued;

“Attagging is where a ‘genuine QR code’ is replaced by a ‘cloned QR code’ which then redirects the person scanning that code to a similar website where personal data can be intercepted and breached.

“The problem is that serious that in India alone there are over 1 billion fraudulent financial transactions each day using QR codes. As the scanning user journey is the same, it is only tech savvy individuals that may notice the domain name has changed.”

As reported by a recent Forbes Magazine investigation, it is predicted that over 11 Million households in the US alone will scan a QR code this year and the majority of them, some 71% of people who have interacted with a QR code will not know if it is the start of a malicious hack. It is envisaged that over 5.3 Billion QR codes will be redeemed this year making it one of the fastest growing tech scanning interactions and also posing one of the greatest cyber threats.

QR codes can be cloned and redirected to other information points or websites. Often criminals and hackers will exploit this by putting a fake QR code over a genuine QR code. So a QR code for example on scanning would link to the genuine website at: www.similardomain.com  but a fake QR code can be made up printed off and placed over the genuine code to redirect to www.similar-domain.com at this point the member of the public is tricked into entering their personal information, private data and financial information. The rogue website looks and feels exactly like the genuine one and is made to mirror it precisely.

VCode which is the ultra-secure digital code which powers the V-Health Passport cannot be cloned. Even if it was printed off, or a photograph was taken and placed over a VCode® or V-Health Passport it simply won’t scan as it works on a call and response system of information between the code and web platform to verify location of the code, user ID and time and date and much more.” 

Louis-James Davis said; “We developed and built the V-Health Passport and health wallet to be the most secure technology on the planet that you could use as a health passport where you could combine your test status, vaccination record, boarding pass, airline ticket, music or sports ticket all in one app.

“With V-Health Passport we wanted to provide functionality and greater mobility to allow citizens to return to work, be fit to fly or return to the sports stadiums. But at the heart of the technology was the ability to protect and respect data privacy of the individual.

“The lack of engagement and interaction by the public with Government track and trace app/s over the pandemic was over privacy, security of data and the tracking of a person’s live location. This is why we have built a unique system in the vein of ‘Self Sovereign ID’ with the ethics of privacy & security by design. The V-Health Passport puts the citizen in control in a way which they share information with who, when and where.”

By having a technology health wallet which confirms your Covid test status and your vaccination record/s it then becomes a ‘safe technology enabler’ to assist Governments, companies, consumers and organisations to resume greater mobility and returning life back to normality. But critically this technology will help revive and restore economic prosperity.

V-Health Passport will help employers safely return their employees back to their offices, factories and warehouses. It will facilitate airlines to allow their passengers to be fit to fly and avoid the need for quarantine restrictions. At the same time it will ensure their airline ticket or boarding pass is secure and won’t be hacked.

V-Health Passport will allow sports fans to return to the stadiums at capacity and not at the current socially distanced crowd protocols of 2000 fans. It will help get the hospitality sector back on its feet welcoming customers back. Because of the way V-Health Passport™ is designed - based on interaction and incentive - the hospitality sector can engage with unique offerings and discounts to its customers. 

V-Health Passport will help the live music and entertainment sectors resume their concerts and performances in arenas, stadiums and theatres. They will be safe in the knowledge that fans have either been tested or vaccinated and can authenticate their status. 

A citizen will be able to share their health pass and confirm their Covid test status, or present their vaccination record. They will also be able to show their credit score, work permit or visa, scan their travel or event pass. 

At the heart of each interaction they will have peace of mind that their data and information is highly secure and ultimately, they control who sees what, who scans what, where and when. 

Relatives of people living in care homes in England will be able to visit over Christmas if they test negative for Covid-19, the government has said.

More than a million coronavirus tests will be sent to care homes over the next month to allow safe indoor visits. Visits will be able to happen across all tiers of coronavirus restrictions starting from today.

The health secretary said the move was possible due to "unprecedented strides" in testing technology and capacity.

Matt Hancock said: "The separation has been painful but has protected residents and staff from this deadly virus.

"I'm so pleased we are now able to help reunite families and more safely allow people to have meaningful contact with their loved ones by Christmas."

Strict restrictions have been placed on visits to care homes during the last eight months because of the pandemic.

In new guidance, the Department of Health and Social Care (DHSC) says the "default position" is that visits should be enabled to go ahead in all tiers - unless there is an outbreak in the care home.

It adds that hand holding and hugging may be possible if other infection control measures are followed. It stresses the importance of visitors minimising contact as much as possible and wearing personal protective equipment (PPE) to help protect their loved ones.

More than a million quick-turnaround or "lateral flow" tests, which provide results in about 20 minutes without the need for a lab, are being sent out to England's 385 biggest care homes as part of the first phase of the rollout.

It is understood that all care homes will receive enough tests so they can provide visits by Christmas if safe to do so, with visits starting from today.

As well as the tests, an extra 46 million items of PPE will be sent to Care Quality Commission (CQC)-registered care home providers.

The latest research* carried out by new Hypochlorous hand sanitiser Steril-eeze released today has revealed that worryingly, we are relaxing our hand hygiene, with 25% fewer people now hand sanitising up to five times a day than in lockdown one. Nearly a quarter of us cite the forthcoming vaccine as the reason for relaxing our hand hygiene, with a fifth saying they are less scared of the impact of the virus and some also blaming laziness and the impact of hand sanitiser on their skin, or ‘lockdown hands’.

Says Dr Sarah Jarvis, Medical Advisor to Steril-eeze, “Hand hygiene is so important. Always have a hand sanitiser with you for when you’re out and about and can’t access soap and water or if you need to sanitise a door handle or surface. Hand sanitisers that contain at least 60% alcohol are highly effective. However, if you find your skin is irritated and dry as a result of these, hand sanitiser containing 300 PPM (parts per million) hypochlorous acid can offer an effective alternative which is kinder to skin."

Steril-eeze is 99.99% effective against viruses and bacteria, contains 300 PPM hypochlorous acid, and it’s alcohol-free, non-sting, and doesn’t irritate or dry out skin, so it’s kind to hands.

Up to three households will be able to meet up during a five-day Christmas period of 23 to 27 December, leaders of the four UK nations have agreed.

People can mix in homes, places of worship and outdoor spaces, and travel restrictions will also be eased. But a formed "Christmas bubble" must be "exclusive" and would not be able to visit pubs or restaurants together.

The leaders urged people to "think carefully about what they do" to keep the risk of increased transmission low. They added 2020 "cannot be a normal Christmas" but family and friends will be able to see each other in a "limited and cautious" way.

The measures will see travel restrictions across the four nations, and between tiers and levels, lifted to allow people to visit families in other parts of the UK. Anyone travelling to or from Northern Ireland may travel on the 22 and 28 December, but otherwise travel to and from bubbles should be done between the 23 and 27. People will not be able to get together with others from more than two other households, and once a bubble is formed, it must not be changed or be extended further.

The guidance says a bubble of three households would be able to stay overnight at each other's home but would not be able to visit hospitality, theatres or retail settings.

The leaders of England, Scotland, Wales and Northern Ireland reached the agreement at a meeting on Tuesday afternoon.

In a joint statement, they said: "Even where it is within the rules, meeting with friends and family over Christmas will be a personal judgement for individuals to take, mindful of the risks to themselves and others, particularly those who are vulnerable.

"Before deciding to come together over the festive period we urge the consideration of alternative approaches such as the use of technology or meeting outside."

Published guidance for England gives further details of the rules:

• People can continue to meet people outside their Christmas bubble outdoors according to the rules in the tier where they live
• Children under the age of 18 whose parents do not live together may be part of both parents' Christmas bubbles
• Existing support bubbles count as one household towards the three household limit
• People are allowed to form a different Christmas bubble from the people they live with normally - they can choose to stay with different people for this period
• If a care home resident is able to leave their home, they can form a bubble with one other household - but should not form a three-household bubble. However, visits out of care homes should only be considered for residents of working age because of the risks
• Students are considered to be part of the household to which they have returned

Scientists say a typical Christmas gathering at home is the type of environment where infections can spread.

The guidance also advises people to take precautions when meeting their Christmas bubble such as washing hands frequently and opening windows to clear potential virus particles.

In a video message from Downing Street, the prime minister described the agreement as a "special, time-limited dispensation", saying: "This year means Christmas will be different."

Boris Johnson said people must make a "personal judgment" about the risk of who they form a bubble with or if they visit elderly relatives., adding: "Many of us are longing to spend time with family and friends... And yet we can't afford to throw caution to the wind."

Wales' First Minister Mark Drakeford said it was "not an instruction to travel, it's not an instruction to meet with other people. People should still use a sense of responsibility".

Scotland's First Minister Nicola Sturgeon added: "The virus is not going to be taking Christmas off, so although we want to give a little bit of flexibility for Christmas we are still urging people to be very cautious and to use this flexibility responsibly and only if you think it is necessary."

Northern Ireland's First Minister Arlene Foster said she hoped people would have space to plan, adding: "We of course recognise how important Christmas time is for so many people."

Deputy First Minister Michelle O'Neill urged people to "be responsible", saying while they wanted to mark Christmas after such a "desperate" year the relaxations would increase opportunities for the virus to spread.

She added it was hoped that an alignment with rules in the Irish Republic could be achieved.

Mauritian Prime Minister Pravind Jugnauth calls for Covid-19 vaccines to be ‘distributed fairly’ amid fears that some parts of the world might be left behind in the dash for coronavirus immunity.

Mr Jugnauth calls upon world leaders to ensure that no countries miss out on the crucial vaccines once they are approved for use and for governments to continue coordination efforts the World Health Organisation.

“The Covid-19 pandemic has laid bare the inequalities that exist amongst nations and this is nowhere more evident than in the area of having fair and equal access to safe, effective, and affordable COVID-19 vaccines,” said Mr Jugnauth. “Access is key to changing the course of the pandemic and help those countries experiencing catastrophic economic and fiscal impacts to move toward a resilient recovery.

“We call for global leadership and coordinated response to ensure that any approved vaccine is distributed equitably.”

Around 150 vaccines against Covid-19 are currently in development around the world but three have emerged as the front runners in the race for immunisation: Pfizer/BioNtech,

Oxford University/AstraZeneca and Moderna. Initial trials for all three have shown promising results but there is still a long way to go before they are given the green light.

Even with an accelerated timetable the first doses will not be available until the end of the year at the earliest and then only to a limited amount of people in countries who have placed orders for the vaccines. Widespread vaccination is unlikely to happen until the second half of 2021 and then the question is how will less wealthy nations fare in the race for the vaccine with experts predicting lower and middle-income countries might not get mass immunisation until 2022.

The island nation of Mauritius has already pre-ordered vaccines for 20 per cent of the population which will go to the country’s front-line staff and those most vulnerable to the virus. Mauritius has a population of around 1.3 million people, many living in densely populated areas, but due to an early lockdown and strict quarantine measures managed to reduce the impact of Covid-19 to just 478 cases and 10 deaths.

Speaking at the closing day of the fifth edition of Qatar Foundation’s WISH 2020 summit, Jugnauth told attendees how Mauritius contained the virus thanks to a multi-layered response including a strict regime of PCR testing, 14-day quarantine, isolation and treatment as part of the government’s containment strategy.

Even those it has a relatively ageing population with a high percentage of diabetes and cardiovascular morbidity, Mauritius scored a perfect 100 on the Oxford University Stringency Index that tracks government policy and action with regard to COVID-19.

“Considering our circumstances, our response has been heralded as one of the most efficient in the world as we managed to contain, in a matter of six weeks, the virus which reached our shores on the 18th of March,” said Mr Jugnauth.

However, he added that the unprecedented scope and magnitude of pandemic continued to pose challenges for Mauritius, particularly the “drying up of international visitor numbers, in terms of both business and tourism.”

To mitigate the impact, Jugnauth said his government is providing economic, income and job support to affected sectors of the economy.

“As a centrepiece of our own recovery policy, my Government is committed to injecting significant national resources which will total almost 30 per cent of the country’s GDP, to support and build the economic recovery of Mauritius,” he said.

One positive impact of the pandemic was that there was an increased interest from young people in following careers in medicine and public health as well as STEM subjects, he said.

“If one thing positive can come out from 2020 it is that adversity builds commitment, and hope brings resilience,’ he said. ‘This is a war that we, and specially our youth, will not forget and will grow from.”

WISH is Qatar Foundation’s global health initiative.

The impact of a new Covid vaccine will kick in significantly over summer and life should be back to normal by next winter, one of its creators has said.

Professor Ugur Sahin, BioNTech co-founder, also raised hopes the jab could halve transmission of the virus, resulting in a "dramatic reduction in cases".

Last week, BioNTech and co-developers Pfizer said preliminary analysis showed their vaccine could prevent more than 90% of people from getting Covid-19. About 43,000 people took part in tests.

Prof Sahin said he expected further analysis to show the vaccine would reduce transmission between people as well as stop symptoms developing in someone who has had the vaccine.

"I'm very confident that transmission between people will be reduced by such a highly effective vaccine - maybe not 90% but maybe 50% - but we should not forget that even that could result in a dramatic reduction of the pandemic spread," he said.

The UK is expected to get 10 million doses of the BioNTech/Pfizer vaccine by the end of the year, with a further 30 million doses already ordered. The jab, which was trialled in six countries, is given in two doses, three weeks apart. Older residents and staff in care homes are likely to be prioritised, followed by health workers and the over-80s. People would then be ranked by age.

The UK government announced another 24,962 confirmed Covid cases on Sunday, as well as a further 168 deaths within 28 days of a positive test.

After the announcement of the world's first effective vaccine came, Sir John Bell, regius professor of medicine at Oxford University, suggested life could be back to normal by spring.

"I am probably the first guy to say that, but I will say that with some confidence," he said.

However, Prof Sahin said it would take longer. If everything continued to go well, he said, the vaccine would begin to be delivered at the "end of this year, beginning of next year".

He said the goal was to deliver more than 300 million doses worldwide by next April, which "could allow us to only start to make an impact". He said the bigger impact would happen later, adding: "Summer will help us because the infection rate will go down in the summer and what is absolutely essential is that we get a high vaccination rate until or before autumn/winter next year."

Prof Sahin said it was essential that all immunisation programmes were completed before next autumn.

A new vaccine that protects against Covid-19 is nearly 95% effective, early data from US company Moderna shows. The results come hot on the heels of similar results from Pfizer, and add to growing confidence that vaccines can help end the pandemic. Both companies used a highly innovative and experimental approach to designing their vaccines.

Moderna says it is a "great day" and they plan to apply for approval to use the vaccine in the next few weeks. However, this is still early data and key questions remain unanswered.

The trial involved 30,000 people in the US with half being given two doses of the vaccine, four weeks apart. The rest had dummy injections. The analysis was based on the first 95 to develop Covid-19 symptoms. Only five of the Covid cases were in people given the vaccine, 90 were in those given the dummy treatment. The company says the vaccine is protecting 94.5% of people.

The data also shows there were 11 cases of severe Covid in the trial, but none happened in people who were immunised.

Dr Stephen Hoge, the company's president, said he "grinned ear to ear for a minute" when the results came in.

He said: "I don't think any of us really hoped that the vaccine would be 94% effective at preventing Covid-19 disease that was really a stunning realisation." That depends on where you are in the world and how old you are.

Moderna says it will apply to regulators in the US in the coming weeks. It expects to have 20 million doses available in the country. The company hopes to have up to one billion doses available for use around the world next year and is planning to seek approval in other countries too.

The UK has announced that, from spring, it will have five million doses of the Moderna vaccine, enough to vaccinate 2.5 million people. It has already outlined plans that prioritise the oldest people for immunisation.

There are hints it offers some protection in older age groups, who are most at risk of dying from Covid, but there is not full data.

No significant safety concerns have been reported, but nothing, including paracetamol, is 100% safe. Short lived fatigue, headache and pain were reported after the injection in some patients.

"These effects are what we would expect with a vaccine that is working and inducing a good immune response," said Prof Peter Openshaw, from Imperial College London.

Both vaccines use the same approach of injecting part of the virus's genetic code in order to provoke an immune response.

The preliminary data we have seen so far is very similar - around 90% protection for the Pfizer/BioNTech vaccine and around 95% for Moderna's. However, both trials are still taking place and the final numbers could change.

Moderna's vaccine appears to be easier to store as it remains stable at minus 20C for up to six months and can be kept in a standard fridge for up to a month.

Pfizer's vaccine needs ultra-cold storage at around minus 75C, but it can be kept in the fridge for five days.

The Sputnik V vaccine, developed in Russia, has also released very early data which suggests it is 92% effective.

Described it as a "great day for science and humanity", a preliminary analysis shows that the first effective coronavirus vaccine can prevent more than 90% of people from getting Covid-19.

Developed by Pfizer and BioNTech, the vaccine has been tested on 43,500 people in six countries and no safety concerns have been raised, and there are plan to apply for emergency approval to use the vaccine by the end of the month.

A vaccine - alongside better treatments - is seen as the best way of getting out of the restrictions that have been imposed on all our lives.

Dr Albert Bourla, the chair of Pfizer, said: "We are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis."

One of the founders of BioNTech, Professor Ugur Sahin, described the results as a "milestone".

Data shows that two doses, three weeks apart, may be needed with trials - in US, Germany, Brazil, Argentina, South Africa and Turkey – showing that 90% protection is achieved seven days after the second dose.

Sir John Bell, regius professor of medicine at Oxford University, said: "I am probably the first guy to say that, but I will say that with some confidence."

There are still many unanswered questions as this is only interim data.

The biggest question - how long does immunity last - will take months or potentially years to answer.

The data presented is not the final analysis as it is based on only the first 94 volunteers to develop Covid so the precise effectiveness of the vaccine may change when the full results are analysed.

There are also massive manufacturing and logistical challenges in immunising huge numbers of people, as the vaccine has to be kept in ultra-cold storage at below minus 80C.

The vaccine appears safe from the large trials so far but nothing, including paracetamol, is 100% safe.

It has been stressed that not everyone will get the vaccine straight away and countries are each deciding who should be prioritised.

Hospital staff and care home workers will be near the top of every list because of the vulnerable people they work with, as will the elderly who are most at risk of severe disease.

The UK is likely to prioritise older resident in care homes and the people that work there. But it says a final decision has not been made, saying it will depend on how well the vaccine works in different age-groups and how the virus is spreading.

People under 50 and with no medical problems are likely to be last in the queue.

However

Until it has been approved it will not be possible for countries to begin their vaccination campaigns.

The two companies say they will be able to supply 50 million doses by the end of this year and around 1.3 billion by the end of 2021. Each person needs two doses.

The UK should get 10 million doses by the end of the year, with a further 30 million doses already ordered.

A limited number of people may get the vaccine this year.

Pfizer and BioNTech say they will have enough safety data by the third week of November to take their vaccine to regulators.

There are still huge challenges ahead, but the announcement has been warmly welcomed with scientists describing themselves smiling "ear to ear" and some suggesting life could be back to normal by spring.

Who would get it?

Are there any potential problems?

How does it work?

There are around a dozen vaccines in the final stages of testing - known as a phase 3 trial - but this is the first to show any results.

It uses a completely experimental approach - that involves injecting part of the virus's genetic code - in order to train the immune system.

Previous trials have shown the vaccine trains the body to make both antibodies - and another part of the immune system called T-cells to fight the coronavirus.

The UK's chief medical advisor Prof Chris Whitty said the results showed the "power of science" and was a "reason for optimism" for 2021.

The US president-elect Joe Biden said it was "excellent news".

"It is also important to understand that the end of the battle against Covid-19 is still months away," he added.

The UK Prime Minister's official spokesman said the results were "promising" and that "the NHS stands ready to begin a vaccination programme for those most at risk once a Covid-19 vaccine is available".

Prof Peter Horby, from the University of Oxford, said: "This news made me smile from ear to ear.

"It is a relief... there is a long long way to go before vaccines will start to make a real difference, but this feels to me like a watershed moment."

A West Midlands chief executive who openly discussed her clinical depression with staff says company leaders need to be more open about mental health to support workers during the pandemic.

Laura Thomas, chief executive of Citizens Advice Dudley Borough, who has experienced depression since her teens, surprised staff when she told them about her mental health challenges. But she says since revealing her diagnosis the organisation has embraced a more supportive and transparent culture, where staff have thrived both personally and professionally.

The Centre for Mental Health has estimated that half a million people will suffer mental health problems due to the pandemic, and  Ms Thomas believes that CEOs need to be open about improving and sustaining positive mental health, not only to avoid problems within their organisations further down the line but also to harness specific skills, resilience and empathy people with disabilities and health conditions can demonstrate in the workplace.

Ms Thomas made the comments as Citizens Advice Dudley Borough gained Thrive at Work bronze level accreditation, the free scheme run by West Midlands Combined Authority (WMCA) to help employers support the mental and physical health and wellbeing of employees.

She said: “Many leaders say that to successfully head up an organisation you should leave your problems at home. I disagree. As an employer, we should view employees holistically because unsupported mental health issues can and do affect work and that’s why it’s important leaders develop a transparent and supportive culture by being open about their own challenges.”

Thrive at Work has signed up more than 400 organisations across the West Midlands and beyond. As Covid puts new pressures on the workplace, the scheme aims to help bosses support their employees’ physical and mental health and wellbeing, which may be affected by the current situation.

Ms Thomas revealed her health diagnosis during a staff conference when she told employees that she had overcome a period of self-harming, undergone psychiatric assessment and been prescribed a variety of anti-depressants. She said: “When I shared my mental health journey with staff, many were surprised that someone in a senior leadership role could experience such problems. It made them realise that the stigma and discrimination around mental health needs to be challenged and that having a physical and or mental health issue is not a barrier to a successful career and fulfilled life.”

Citizens Advice Dudley Borough recently gained Thrive at Work accreditation.

Ms Thomas said: “We chose to join the programme because we are committed to the wellbeing of our workforce and the principles behind the accreditation. It wasn’t just a tick-box exercise. I was impressed with the support we received, and the rigorous assessment tested the integrity of our organisation’s approach against the outcomes we were aiming to achieve. I chose to disclose my mental health challenges to avoid an ‘us and them’ situation at work. I also wanted to make sure that our staff feel comfortable and safe to share any struggles without judgement or fear of it affecting their employment status.

“One of the positive effects of the programme was an increase in the confidence and self-esteem of staff, where some staff who previously struggled with mental health issues have secured internal and external promotions because of how they have been supported.

“A third of our workforce have a declared physical disability and/or a mental health issue, however since April last year 14% of our paid workforce have achieved a promotion.  Many of these are employees who declared a physical or mental condition. They’ve been able to move up the career ladder because the support offered within the Thrive at Work framework has boosted their confidence and self-esteem.”

Councillor Izzi Seccombe, WMCA portfolio lead for wellbeing and leader of Warwickshire County Council, said: “The wellbeing and mental health of employees makes a considerable contribution to every organisation. More than 400 organisations have been helped by Thrive at Work and as our region continues to face huge challenges both within the workplace and at home, I hope many more will benefit from joining this free programme.”

Another group of talented graduates have joined the City of Wolverhampton Council and are embarking on a career in children’s social work as part of the Frontline training and development programme.

This is the fourth year that the council has teamed up with the charity Frontline to give people a unique route into the profession, through which they will benefit from intensive practical and academic training tailored to their needs.

Dozens of people applied to take part with the successful candidates taking part in a summer institute before arriving in Wolverhampton in September.

Over the next two years they will work with service users and their families while qualifying as a social worker in their first year and working towards a full Masters qualification in their second year, also their Assessed and Supported Year in Employment (ASYE), under the guidance of Consultant Social Worker Claire Beckerleg.

Although the focus of their work will be within children’s social care services, the group will also be given experience of adult social care, disability services and fostering.

Councillor John Reynolds, the City of Wolverhampton Council’s Cabinet Member for Children and Young People, said: “This is the fourth year that we have offered the Frontline programme here in Wolverhampton, giving people a unique introduction to social work, learning through practice whilst they are also supported in their academic studies.

"The programme has so far provided the council with 16 qualified social workers, all of whom have completed an intense programme of both academic and practical studies working with some of our most vulnerable families in Wolverhampton. We are delighted that they have all now taken permanent positions within the council.

"I would like to welcome our latest cohort to Wolverhampton and wish them the very best as they embark on their social work careers with the council.”

The participants include Jazz Johal who said: "The summer institute was intense but extremely insightful and has set the foundations of the core elements of social work practice. The placement gives me the chance to visualise social work in practice and build on the theoretical concepts of social work."

Fellow participant Alex Bailey added: "No two days have been the same since starting the Frontline programme. It has encouraged my personal development and reflection skills and has taught me a lot about myself. Frontline has encouraged me to develop my own style of being a social worker, and although it is challenging it is also very rewarding."

Health Secretary Matt Hancock has said that the NHS will be ready from December to roll out the new coronavirus vaccine if it gets approved.

He said the news about the vaccine was an important step but "there are no guarantees". He also said "we don't know" how many people will need to be vaccinated in order for life to return to normal. And he announced that NHS staff will now begin being tested twice a week.

While the number of deaths recorded is higher than previous days, there is often an increase at the beginning of the week due to delays in weekend reporting.

Early results from the world's first effective coronavirus vaccine showed it could prevent more than 90% of people from getting Covid.

The vaccine has been developed by pharmaceutical companies Pfizer and BioNTech and is one of 11 vaccines that are currently in the final stages of testing.

The companies now plan to apply for emergency approval to use the vaccine by the end of November - and a limited number of people may get the vaccine this year.

The UK has already ordered 40 million doses - enough to vaccinate up to 20 million people, as each person will need two doses for it to work effectively. But Prime Minister Boris Johnson warned people not to "rely on this news as a solution" as it is still "very, very early days".

Speaking in the Commons, Mr Hancock said: "If this or any other vaccine is approved, we will be ready to begin a large-scale vaccination programme.

"We do not yet know whether or when a vaccine is approved, but I have tasked the NHS with being ready from any date from 1 December." Earlier, hea said the bulk of the rollout of a vaccine was always expected to be in the first part of 2021.

Asked about how many people would need to be vaccinated, Mr Hancock said: "The honest truth to that question is we don't know what proportion of the population vaccination needs to reach in order for this to stop the epidemic.

"The reason we don't know that is you can check in a clinical trial for the impact of the vaccine on protecting the individual... what you cannot check is the impact on the transmission of the disease by those people, because you have to have enough of the population, a significant proportion of the population, to have had the vaccine to understand that."

He said that vaccinations would take place in care homes, centres such as sports halls and also clinics that would open seven days a week. He also said he was giving GPs an extra £150m to help with the roll-out, and he believed NHS staff "will rise to this challenge of being ready when the science comes good to inject hope into millions of arms this winter".

"There are many hard days ahead, many hurdles to overcome, but our plan is working and I'm more sure than ever that we will prevail together."

Mr Hancock added that new rapid swab tests - which give results in less than an hour - will be made available across 67 local areas, after they were used in a mass testing trial in Liverpool.

Older care home residents and care home staff are at the top of a list from government scientific advisers of who should be immunised first, followed by health workers.

The Covid vaccine is the fastest ever vaccine to go from the drawing board to being proven highly effective. It will not be released for use until it passes final safety tests and gets the go-ahead from the Medicines and Healthcare products Regulatory Agency.

"Our strong and independent regulator the MHRA will not approve a vaccine until it's clinically safe," Mr Hancock said.

The British Medical Association, which represents doctors, said GPs have been told to prepare to give patients two vaccine doses - to be delivered between 21 and 28 days apart - during clinics that could run between 08:00 and 20:00 GMT seven days a week.

It added that, due to the logistics and delivery requirements, including the need to store it at very cold temperatures, it was likely that groups of GP practices would need to work together with one "designated vaccination site".